 pharmacologic thrombolysis appears to be unwarranted, the selective use of such
devices in high-risk situations remains controversial. Patients with thrombus extending into the IVC and those
undergoing pharmacomechanical thrombolysis71,73 are
often deemed to be at higher risk for PE and to warrant
consideration for retrievable filter placement.69,86 Unfortunately, little reliable data are available to support or
refute this position.
Among 68